BARCLAYS PLC - ATEA PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of ATEA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$77
+35.1%
25,619
+67.8%
0.00%
Q2 2023$57
-56.2%
15,271
-60.6%
0.00%
Q1 2023$130
+3.2%
38,759
+48.6%
0.00%
Q4 2022$126
-99.9%
26,082
-29.6%
0.00%
Q3 2022$211,000
-36.6%
37,023
-21.1%
0.00%
Q2 2022$333,000
-25.7%
46,940
-24.3%
0.00%
Q1 2022$448,00062,0100.00%
Other shareholders
ATEA PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
AJU IB Investment Co., Ltd. 1,637,331$57,405,00037.04%
Bain Capital Life Sciences Investors, LLC 3,700,000$129,722,0008.05%
Cormorant Asset Management, LP 4,928,756$172,802,0007.02%
RA Capital Management 5,427,655$190,294,0002.64%
CM Management, LLC 100,000$3,506,0002.62%
Ghost Tree Capital, LLC 150,000$5,259,0001.54%
ORACLE INVESTMENT MANAGEMENT INC 309,126$10,838,0001.35%
Perceptive Advisors 2,259,224$79,208,0001.15%
Omega Fund Management, LLC 164,577$5,770,0000.65%
Monashee Investment Management LLC 100,000$3,506,0000.65%
View complete list of ATEA PHARMACEUTICALS INC shareholders